» Articles » PMID: 2457329

Efficiency and Capacity of Protein Synthesis Are Increased in Pressure Overload Cardiac Hypertrophy

Overview
Journal Am J Physiol
Specialty Physiology
Date 1988 Aug 1
PMID 2457329
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We measured the rate of protein synthesis and total RNA content in the right ventricle (RV) at day 2 and day 4 after pulmonary artery constriction to determine the contributions of changes in capacity and efficiency of in vivo protein synthesis to pressure overload (PO) cardiac hypertrophy. A significant increase in the proportion of RV weight to total heart weight was observed at day 2 and day 4 when compared with untreated controls. The rate of protein synthesis was significantly higher at day 2 post-PO (0.31 +/- 0.06 day-1 or 30 +/- 5 mg.g RV-1.day-1, means +/- SD, P less than 0.05) as well as at day 4 (0.25 +/- 0.05 day-1 or 28 +/- 9 mg.g RV-1.day-1, P less than 0.05) than for untreated rabbits (0.15 +/- 0.03 day-1 or 17 +/- 4 mg.g RV-1.day-1). RNA content was significantly higher at day 2 (1.47 +/- 0.17 mg/g RV, P less than 0.05) than in controls (1.16 +/- 0.14 mg/g RV), whereas there was a slight but nonsignificant increase at day 4 (1.36 +/- 0.21 mg/g RV, P less than 0.1). The efficiency of protein synthesis (synthesis/RNA) per gram RV was significantly increased both at day 2 (20.5 +/- 2.2 g protein.g RNA-1.day-1, P less than 0.05) and day 4 (19.8 +/- 3.5 g protein.g RNA-1.day-1, P less than 0.05) compared with control (14.6 +/- 2.3 g protein.g RNA-1.day-1). The increase in efficiency appeared to be caused by pressure overload itself based on a comparison of 0-4 day data vs. data obtained from sham animals (P less than 0.05).

Citing Articles

Hassk. Empty Pod Extract Prevents Cardiomyocyte Hypertrophy by Inhibiting MAPK and Calcineurin-NFATC3 Signaling Pathways.

Mustafa N, Jalil J, Saleh M, Zainalabidin S, Asmadi A, Kamisah Y Life (Basel). 2023; 13(1).

PMID: 36675993 PMC: 9864749. DOI: 10.3390/life13010043.


Translating Translation to Mechanisms of Cardiac Hypertrophy.

Zeitz M, Smyth J J Cardiovasc Dev Dis. 2020; 7(1).

PMID: 32164190 PMC: 7151157. DOI: 10.3390/jcdd7010009.


TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation.

Grund A, Szaroszyk M, Korf-Klingebiel M, Malek Mohammadi M, Trogisch F, Schrameck U EMBO Mol Med. 2019; 11(10):e10018.

PMID: 31468715 PMC: 6783653. DOI: 10.15252/emmm.201810018.


Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.

Sansbury B, DeMartino A, Xie Z, Brooks A, Brainard R, Watson L Circ Heart Fail. 2014; 7(4):634-42.

PMID: 24762972 PMC: 4102656. DOI: 10.1161/CIRCHEARTFAILURE.114.001151.


In vivo measurements of the contributions of protein synthesis and protein degradation in regulating cardiac pressure overload hypertrophy in the mouse.

McDermott P, Baicu C, Wahl S, Van Laer A, Zile M Mol Cell Biochem. 2012; 367(1-2):205-13.

PMID: 22610791 DOI: 10.1007/s11010-012-1334-7.